Table 1

Clinical characteristics of T2D patients in the two prospective cohorts

JKS (n = 416)GMS (n = 826)
Males (%)57.049.3
Age at study entry (years)57.6 ± 9.562.3 ± 9.7
Age at diabetes diagnosis (years)43.8 ± 9.051.3 ± 10.4
Diabetes duration (years)13.9 ± 8.011.0 ± 9.1
BMI (kg/m2)29.9 ± 6.531.0 ± 5.8
HbA1c (%)8.40 ± 1.68.65 ± 1.9
CKD71 (17.5)144 (17.8)
Albuminuria
 Normoalbuminuria217 (52.1)546 (69.5)
 Microalbuminuria114 (27.4)196 (24.9)
 Macroalbuminuria85 (20.4)44 (5.6)
Glucose-lowering therapy
 Diet only31 (7.5)137 (18.6)
 Oral agents119 (28.6)344 (41.6)
 Insulin with/without oral agents266 (63.9)345 (41.8)
Follow-up
 Years12.8 ± 5.87.5 ± 2.2
 py5,340.26,165.6
Deaths, n (%)215 (51.7)164 (19.9)
  • Continuous variables are reported as the mean ± SD; categorical variables are reported as total frequencies, with percentages in parentheses.